SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData Read more
EMA approves label update for Takeda’s HYQVIA, expands use to treat secondary immunodeficiencies Read more
Life sciences companies revisiting their EU strategies want to understand the Irish proposition better Read more
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData Read more